The intelligence and clinical instinct behind your innovation are the rare part- and are entirely yours. What your innovation needs next is a different mastery; the knowledge, structure, and relationships that carry an idea from insight to market.
You built something that could help patients.
Getting it to them takes more than a great idea-it takes time, a clear path, and the right connections. That is exactly what Synera Advisory brings.
The Clinical Commercialization Assessment is where it starts: an honest, agnostic expert read on where your innovation stands, and exactly what it needs next.
A single $995 decision and the clarity that de-risks your next $5 Million.
Your least renewable asset.
Commercialization is a full-time job and you already have one, caring for patients and continuing to build. You shouldn't have to choose between them. We do the work so you dont have to.
Discipline, Not a Document.
You dont need to reinvent the plan. Turning an idea into a fundable, bulidable plan follows our proven playbook-regulatory steps, evidence milestones, and just the right timing. We have run it many times before, so you dont have to figure it out from scratch.
You can't build the network overnight.
The right advisors, regulators, health systems, manufacturing, distributor relationships and investors take years to develop. We already know them and we open our doors to you.

The Clinical Commercialization Assessment (TM) is a clear evaluation of your innovation across the four things that decide your success: clinical value, regulatory path, commercial viability, and strategy. It is completed by physician founders, former FDA reviewers, and people who have brought products to market. No equity. No sales pitch. Just a straight expert answer that is scored and easy to act on.
Four Dimensions. One Clear Verdict.
1. Clinical: Clinical Value Proposition-
Is the unmet need real and defensible? Would practicing clinicians change behavior for it?
Is the indication and evidence strategy credible to the people who will actually use and pay for it?
2. Regulatory: Regulatory and Compliance Readiness
The pathway that actually fits- across FDA (510(k), DeNovo, PMA), EU MDR/IVDR, UKCA, and other target markets plus quality-system and data governance exposure surfaced early.
3. Commercial: Commercial and Market Readiness
Reimbursement and coding reality, the true buying center, pricing and economic model, and whether adoption is achievalbe in the settings you are targeting.
4. Strategy: Strategic and Operational Readiness
Investor-readiness, the milestones that genuinely de-risk the next round, IP and team gaps, and the sequence of moves that gets you to the next stage fastest.

Dr. Raheel Sohail is a physician-executive and healthcare strategist with deep expertise in population health, integrated care models, and complex clinical operations. With experience spanning hospitals, clinically integrated networks, accountable care organizations, and national healthcare enterprises.
Dr Sohail brings a uniquely balance
Dr. Raheel Sohail is a physician-executive and healthcare strategist with deep expertise in population health, integrated care models, and complex clinical operations. With experience spanning hospitals, clinically integrated networks, accountable care organizations, and national healthcare enterprises.
Dr Sohail brings a uniquely balanced perspective that blends clinical insight, operational excellence, and scalable systems thinking.Across his career, Dr. Sohail has led strategic initiatives for major healthcare organizations including Adventist Health, CVS Health, Miliman, Albertsons, and Prospect Medical Systems-where he shaped next generation care delivery models, strengthened physician network performance, redesigned value based care programs, and improved operational efficiency across multi-site sytems. His work includes developing large scale ACO strategies across hospitals and independent physician associations, designing population health programs that reduce cost and improve outcomes, advising digital health and MedTech innovators, and guiding executive leaders through high impact business decisions. He has also served as an advisor for multiple emerging health technology companies, providing clinical and operational insight to support product design, adoption pathways, and market readiness. A collaborative communicator and analytical strategist.
Dr. Sohail excels at bridging the gap between clinical leadership, administrative executives, and innovation teams. He holds an MD and an MBA, combining clinical training with advanced business and management expertise-positioning him as a uniquely effective leader in today's rapidly evolving healthcare landscape.

Dr. Peter Papapetrou is a board-certified anesthesiologist and pain management phyisician with specialized expertise in interventional spine care, chronic pain syndromes, and procedural based therapeutics. He brings a clinically rigorous and sytems-level understanding of pain medicine, making him highly valuable in evaluating and commerci
Dr. Peter Papapetrou is a board-certified anesthesiologist and pain management phyisician with specialized expertise in interventional spine care, chronic pain syndromes, and procedural based therapeutics. He brings a clinically rigorous and sytems-level understanding of pain medicine, making him highly valuable in evaluating and commercializing technologies across spine, neuromodulation, and minimally invasive interventions.
Dr. Papapetrou completed his medical degree at Wayne State University School of Medicine and went on to complete an advanced fellowship training in Pain Medicine at NYU Langone Medical Center- one of the leading programs in interventional pain and neuromodulation.
Clinically, his work spans high-volume managment of complex pain conditions, and procedural experience includes nerve blocks, spinal injections, neruolytic therapies, and advanced interventional pain techinques, positining him at the intersection of device-based therapies and longitudinal patient management.
In addition to clinical practice, he has contributed to peer-reviewed research in areas including neuropathy treatment and perioperative complications reinforcing a foundation in evidence-based medicine and translational clinical insight.

Dr. Ramez Barsoom is a physician, engineer, innovator, and healthcare strategist whose work bridges frontline clinical care with the development of technologies that improve patient outcomes. His multidisciplinary background spans engineering, internal medicine, digital health, product development, and innovation consulting, allowing him
Dr. Ramez Barsoom is a physician, engineer, innovator, and healthcare strategist whose work bridges frontline clinical care with the development of technologies that improve patient outcomes. His multidisciplinary background spans engineering, internal medicine, digital health, product development, and innovation consulting, allowing him to help founders translate complex clinical challenges into practical and scalable solutions.
As a Physician Advisor with Synera, Dr. Barsoom provides strategic guidance across clinical validation, product development, physician adoption, healthcare innovation strategy, and commercialization planning. His experience working alongside health systems, startups, and multidisciplinary innovation teams enables him to evaluate technologies through both a clinician's and a product developer's perspective.
Dr. Barsoom's career includes leadership roles in healthcare innovation, consulting, and academic medicine. He has advised early-stage healthcare companies, supported clinical product development initiatives, and founded a medical technology company focused on improving point of care diagnostics. His work emphasizes identifying real clinical problems, validating solutions wtih end users, and accelerating responsible innovation.
His expertise is particularly valuable for founders developing technologies that require strong clinical validation, physician engagement, and evidence-based commercialization strategies.

Holly Fabor Tse is a physician executive with over 20 years of experience leading clinical and operational transformation across health systems, ambulatory care, and population health environments. Board certified in Internal Medicine and Pediatrics, Dr. Tse brings a comprehensive persepective across the continuum of care, with expertise
Holly Fabor Tse is a physician executive with over 20 years of experience leading clinical and operational transformation across health systems, ambulatory care, and population health environments. Board certified in Internal Medicine and Pediatrics, Dr. Tse brings a comprehensive persepective across the continuum of care, with expertise spanning primary care, urgent care, inpatient systems, and multi-site clinical operations. Her work focuses on redesigning care delivery models to improve outcomes, strengthen physician enagement, and drive sustainable performance in complex health environments.
Dr. Tse most recently served as Vice President and Chief Medical Officer within a large integrated health system, where she held enterprise responsibility for clinical quality, patient safety, physician engagement, and operational performance. Her leadership contributed to measurable improvements in health systems outcomes, including significant reductions in hospital acquired infections and decreased in patient length of stay. She is the Founder and Principal of Novella Insights, an independent physician executive advisory practice focused on clinical transformation, ambulatory care redesign, and integration of AI-enabled workflows into value-based care delivery.
At Synera, Dr. Tse serves as a phsyician executive advisor supporting health systems strategy, digital health integration, clinical workflow optimization, and value-based care alignment.

Dr. Sura Edmond is an OB/GYN physician, healthcare strategist, and medical affairs advocate and leader with extensive experience advising medical device, digital health, and healthcare technology organizations. Her career contributions combine frontline clinical expertise, with strategic leadership across product development, regulatory s
Dr. Sura Edmond is an OB/GYN physician, healthcare strategist, and medical affairs advocate and leader with extensive experience advising medical device, digital health, and healthcare technology organizations. Her career contributions combine frontline clinical expertise, with strategic leadership across product development, regulatory strategy, market access, clinical research and commercialization.
As a Physician Advisor with Synera Advisory, Dr. Edmond partners iwth innovators to translate emerging healthcare technologies into clinically relevant, evidence-based solutions that improve patient care and accelerate adoption. Her multidisciplinary background enables her to bridge the perspective of clinicians, industry, regulators, and healthcare systems throughout the innovation lifecycle.
Dr. Edmond has advised early stage MedTech and digital health companies, served as a scientific and medical advisor across multiple healthcare organizations, and contributed to initiatives involving clinical trial strategy, FDA regulatory policy, health equity, medical communications, and cross-sector healthcare partnerships. Her experience spans both private industry and healthcare consulting, where she has supported organizations ranging from early-stage startups to established healthcare enterprises.
Recognized for her ability to transform complex clinical and scientific information into actionable business strategy, Dr. Edmond provides valuable insight into physician adoption, evidence generation, and healthcare commercialization. Her work reflects a commitment to advancing innovative technologies while improving patient outcomes and expanding access to high-quality care.

Dr. Erica Kreisman is a board-certified Emergency Medicine physician, executive healthcare leader, and physician strategist with more than two decades of experience spanning clinical medicine, academic leadership, emergency medical services, executive administration, and physician development. Her career reflects a unique combination of f
Dr. Erica Kreisman is a board-certified Emergency Medicine physician, executive healthcare leader, and physician strategist with more than two decades of experience spanning clinical medicine, academic leadership, emergency medical services, executive administration, and physician development. Her career reflects a unique combination of frontline clinical excellence, executive leadership, and organizational transformation.
As a Physician Advisor with Synera Advisory, Dr. Kreismann advises healthcare innovators, founders, and executive teams on clinical strategy, physician engagement, healthcare operations, leadership development, and enterprise adoption. Drawing upon extensive experience leading emergency medical departments, statewide emergency medical systems, and multidisciplinary healthcare organizations, she helps organizations navigate complex clinical environments while building sustainable leadership cultures.
Throughout her career, Dr. Kreismann has served in executive medical leadership roles across hospital systems, emergency medical programs, aeromedical retrieval services, and academic institutions. Her experience includes serving as Executive Medical Director

Dr. Joe Littlejohn, Jr. is a board-certified urologic surgeon, healthcare innovator, and health technology entrepreneur with more than two decades of experience advancing patient care through clinical excellence and digital innovation. He currently serves as Division Chief of Urology at Northwell Health while leading efforts to improve p
Dr. Joe Littlejohn, Jr. is a board-certified urologic surgeon, healthcare innovator, and health technology entrepreneur with more than two decades of experience advancing patient care through clinical excellence and digital innovation. He currently serves as Division Chief of Urology at Northwell Health while leading efforts to improve physician efficiency, patient engagement, and healthcare delivery through technology.
As Founder and CEO of LinkBox Solutions, Dr. Littlejohn has developed physician-centered digital health solutions designed to streamline clinical workflows, improve documentation efficiency, and enhance the patient experience. His unique perspective bridges frontline clinical practice with healthcare technology development, providing valuable insight into the successful commercialization and implementation of innovative medical solutions.
Dr. Littlejohn completed his medical degree at the University of Connecticut School of Medicine, residency training in Urology at Howard University Hospital, and Fellowship training in Neuro-Urology and Voiding Dysfunction at Columbia Presbyterian Medical Center. Throughout his career he has held academic leadership appointments, published on advanced urologic therapies, and remains commited to advancing evidence-based patient-centered care.

Dr. Loubert Suddaby is a practicing neurosurgeon, medical device inventor, and biomedical systems innovator whose career has been dedicated to advancing surgical technologies through thoughtful engineering and clinically driven design. With decades of experience in neurological surgery and numerous patented medical technologies, he brings
Dr. Loubert Suddaby is a practicing neurosurgeon, medical device inventor, and biomedical systems innovator whose career has been dedicated to advancing surgical technologies through thoughtful engineering and clinically driven design. With decades of experience in neurological surgery and numerous patented medical technologies, he brings an uncommon ability to bridge complex clinical challenges with scalable engineering solutions.
Throughout his career, Dr. Suddaby has focused on improving mechanical systems used in spine surgery by replacing traditional force-dependent approaches with precise, controlled modulation. His work has led to the development of innovative implant architectures, expandable spinal technologies, translational mechanical systems, and biologically integrated device platforms designed to improve surgical precision while reducing procedural complexity.
In addition to his extensive neurosurgical experience, Dr. Suddaby is an inventor and entrepreneur developing next generation technologies across spine surgery, musculoskeletal reconstruction, dental applications, osteoimmunity, and energy based medical platforms. His philosophy emphasizes elegant engineering, simplified surgical workflows, and technologies that improve patient outcomes while maintaining procedural efficiency.
As a Physician Advisor to Synera Advisory, Dr. Suddaby provides strategic expertise spanning innovation, product development, intellectual property strategy, and commercialization of advanced medical technologies. His experience enables Synera clients to evaluate complex technologies through both a surgeon's clinical lens and an inventor's engineering perspective helping organizations de-risk product dvelopment while accelerating commercialization and physician adoption.

Dr. Bruce Pinker is a board-certified podiatric surgeon, healthcare entrepreneur, educator, and nationally recognized thought leader dedicated to advancing lower extremity care through clinical innovation, technology and patient-centered medicine. As Founder of Progressive Foot Care, he has spent more than two decades building one of New
Dr. Bruce Pinker is a board-certified podiatric surgeon, healthcare entrepreneur, educator, and nationally recognized thought leader dedicated to advancing lower extremity care through clinical innovation, technology and patient-centered medicine. As Founder of Progressive Foot Care, he has spent more than two decades building one of New York's premiere multi-disciplinary foot and ankle practices while continually integrating emerging technologies to improve patient outcomes.
Beyond clinical practice, Dr. Pinker has established himself as an innovator and advisor across healthcare, serving on multiple advisory boards supporting digital health, artificial intelligence, medical technology, and healthcare innovation. His experience evaluating new technologies from both the physician and entrepreneur perspectives enables him to provide valuable strategic guidance to companies developing solutions for today's evolving healthcare landscape.
Dr. Pinker is also the founder of Dr. D-Lucs, a custom footwear company that combines biomechanics, gait analysis, diagnostic imaging, and personalized orthotic design to improve patient mobility, comfort, and long-term musculoskeletal health. His work reflects a commitment to translating clinical insight into scalable healthcare solutions that enhance quality of life. Known as the "The Shoe Doctor", Dr. Pinker is an accomplished speaker, educator, media contributor, and healthcare advocate who is frequently recognized for his expertise in podiatric surgery, diabetic limb preservation, sports medicine, biomechanics, and emerging health technologies. His philanthropic leadership including longstanding community initiatives focused on preventing lower extremity disease and amputations reflects a career dedicated to improving patient care beyond the clinic.
As a Physician Advisor to Synera Advisory, Dr. Pinker provides strategic insight across lower extremity innovation, digital heatlh, physician adoption, commercialization strategy, and patient-centered product development, helping innovators develop technologies that are clinically meaningful, commercially scalable, and aligned with the needs of physicians and patients.

Dr. Alexey Sorokin, is a board-certified cardiologist, cardiovascular innovator, and founder of Cardionyx, where he is developing next-generation technologies to advance the treatment of cardiovascular disease. With more than 20 years of clinical experience, he combines frontline patient care with medical innovation to address critical un
Dr. Alexey Sorokin, is a board-certified cardiologist, cardiovascular innovator, and founder of Cardionyx, where he is developing next-generation technologies to advance the treatment of cardiovascular disease. With more than 20 years of clinical experience, he combines frontline patient care with medical innovation to address critical unmet needs in cardiovascular medicine.
As a physician innovator and Synera Advisory client and strategic partner, Dr. Sorokin works alongside the Synera ecosystem to accelerate the commercialization of Cardionyx while contributing his clinical expertise to support other emerging healthcare technologies. His unique perspective as both a practicing cardiologist and medical device founder strengthens physician-led product development, clinical validation, commercialization strategy, and adoption to help innovative technologies reach patients with greater confidence and impact.

Dr. Pamela Simone is a clinical cardiology pharmacist and medical affairs leader with more than a decade of experience spanning cardiovascular medicine, scientific communications, and industry partnerships. Her expertise includes clinical evidence generation, and medical content development, helping bridge clinical practice with the comme
Dr. Pamela Simone is a clinical cardiology pharmacist and medical affairs leader with more than a decade of experience spanning cardiovascular medicine, scientific communications, and industry partnerships. Her expertise includes clinical evidence generation, and medical content development, helping bridge clinical practice with the commercialization of innovative therapies. At Synera Advisory, she supports pharmaceutical technologies and life science innovators through clinical strategy, evidence development, and physician-informed commercialization.

Dr. Jeffry Glinski is an emergency medicine physician, former healthcare CFO, and physician executive with more than 20 years of clinical, operational, and financial leadership experience. His unique background spans frontline emergency medicine, healthcare finance, private equity and venture capital advisory, and MedTech clinical due dil
Dr. Jeffry Glinski is an emergency medicine physician, former healthcare CFO, and physician executive with more than 20 years of clinical, operational, and financial leadership experience. His unique background spans frontline emergency medicine, healthcare finance, private equity and venture capital advisory, and MedTech clinical due diligence, providing a rare perspective on both patient care and healthcare investment.
Within the Synera Advisory ecosystem, Dr. Glinski advises innovators, investors, and executive teams on clinical due diligence, healthcare economics, financial
A clear, board-ready document that scores your technology across all four dimensions with the evidence and the reasoning behind each score, not just a grade.
The specific risks most likely to stall your raise, your filing, or your launch- ranked by how much they threaten the company so you know what to fix first.
The highest- leverage next moves, sequenced- what to do now, what to do next, and what to stop doing- so every dollar and month goes to the right place.
A working session with the team that reveiwed you, to pressure-test the findings, answer your hardest questions, and align on the path forward.

Everything below is work founders normally pay separate specialists building in silos to handle, and with Synera each piece is reviewed by the Physician Advisory Board above. We bring it all together into one clear verdict, for a small fraction of the cost.

Who Is it For: Founders and Investors
Typical turnaround in a matter of days from receipt of your materials. Sessions are scheduled to your time zone- we are headquartered in Chicago and work with clients worldwide.
When you are ready, we offer simple transparent pricing well below market value.
We price every service well under what market value is. On purpose. Our calling is to make great innovation accessible- so a good idea never dies from lack of resources, and ultimately so it reaches the patient.
Join us and discover what we can do for you.
Copyright © 2025 Synera Advisory - All Rights Reserved. Synera Advisory is committed to protecting your privacy. All content on this website- including logos, branding, graphics, text, documents, and digital assets-is the exclusive property of Synera Advisory and may not be reproduced, distributed, or used without prior written consent. Unauthorized use is strictly prohibited. Synera is a consultative and advisory organization only. Nothing on this site constitutes medical advice. Product availability, indications, regulatory status, and reimbursement vary by country and clinical setting. All partnerships are subject to contracting, compliance review, and applicable laws and regualtions.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.